Review Article

Association of Cancer and the Risk of Developing Atrial Fibrillation: A Systematic Review and Meta-Analysis

Table 2

Patient characteristics of the five studies.

First author and yearAF in CA/NO-CA (%)Mean age, CA/NO-CA (year)Male sex, CA/NO-CA (%)Diabetes, CA/NO-CA (%)Hypertension, CA/NO-CA (%)Smoking, CA/NO-CA (%)Cardiovascular disease, CA/NO-CA (%)BMI, CA/NO-CARace, CA/NO-CA (%)Education, high school, CA/NO-CA (%)

Guzzetti 2008 [8]3.6/1.663.1 ± 12.6/63.6 ± 9.325.7/53.0NANANANANANANA
Erichsen 2012 [7]NA75 (70–79)/74 (70–79)54.1/54.17.1/4.53.3/2.3NA37.7/21.7NANANA
Jakobsen 2015 [9]NA66.5 (66.5–66.5)/NA47.4/NANANANANANANANA
Nouraie 2015 [6]10.1/5.467 (58–78)/56 (48–69)47/5133/2959/5027/3114/13NANANA
Conen 2016 [10]3.8/2.355 (50–61)/53 (49–58)0/03.2/2.630.0/25.853.3/47.5NA25.1 (22.6–28.9)/24.9 (22.5–28.3)White: 96.5/94.943.4/44.4

CA = cancer group; NA = not applicable; NO-CA = noncancer group.